Experimental subretinal neovascularization is inhibited by adenovirus-mediated soluble VEGF/flt-1 receptor gene transfection: a role of VEGF and possible treatment for SRN in age-related macular degeneration
- 25 May 2000
- journal article
- acquired diseases
- Published by Springer Science and Business Media LLC in Gene Therapy
- Vol. 7 (11), 978-985
- https://doi.org/10.1038/sj.gt.3301203
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- The 230 kDa mature form of KDR/Flk-1 (VEGF receptor-2) activates the PLC-γ pathway and partially induces mitotic signals in NIH3T3 fibroblastsOncogene, 1997
- Heterozygous embryonic lethality induced by targeted inactivation of the VEGF geneNature, 1996
- Expression of basic fibroblast growth factor mRNA in developing choroidal neovascularizationCurrent Eye Research, 1996
- Quantitative Analysis of Repeat Adenovirus-Mediated Gene Transfer Into Injured Canine Femoral ArteriesArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- Coordinate expression of vascular endothelial growth factor receptor‐1 (fit‐1) and its ligand suggests a paracrine regulation of murine vascular developmentDevelopmental Dynamics, 1995
- Vasculotropin/Vascular endothelial growth factor is an autocrine growth factor for human retinal pigment epithelial cells cultued in vitroJournal of Cellular Physiology, 1995
- Vascular Endothelial Growth Factor in Ocular Fluid of Patients with Diabetic Retinopathy and Other Retinal DisordersNew England Journal of Medicine, 1994
- Human gene therapyScience, 1992
- A New Model of Experimental Choroidal Neovascularization in the RatAmerican Journal of Ophthalmology, 1989
- Common causes of blindness and visual handicap in the west of Scotland.British Journal of Ophthalmology, 1983